April 16 (Reuters) - Sirnaomics Ltd :
* RECEIVED FDA SPECIFIC GUIDANCE FOR FURTHER DEVELOPMENT OF STP705 FOR TREATMENT OF SQUAMOUS CELL CARCINOMA IN SITU
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
April 16 (Reuters) - Sirnaomics Ltd :
* RECEIVED FDA SPECIFIC GUIDANCE FOR FURTHER DEVELOPMENT OF STP705 FOR TREATMENT OF SQUAMOUS CELL CARCINOMA IN SITU
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Comments